-
Signature
-
/s/ John R. Moore, Attorney-in-Fact for Fox Jonathan C
-
Issuer symbol
-
EWTX
-
Transactions as of
-
02 Jan 2026
-
Net transactions value
-
$0
-
Form type
-
4
-
Filing time
-
05 Jan 2026, 17:33:21 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Fox Jonathan C |
Director |
C/O EDGEWISE THERAPEUTICS, INC., 1715 38TH STREET, BOULDER |
/s/ John R. Moore, Attorney-in-Fact for Fox Jonathan C |
05 Jan 2026 |
0001655016 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
EWTX |
Common Stock |
Award |
$0 |
+473 |
+2% |
$0.000000 |
24,175 |
02 Jan 2026 |
Direct |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Remarks:
1. Consists of restricted stock units granted and released to the reporting person on January 2, 2026, as a Quarterly Retainer Award pursuant to Section 2.4 of the Edgewise Therapeutics, Inc. Outside Director Compensation Policy, as amended.